Related Experiment Video

Updated: Jun 5, 2026

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

A combined preclinical therapy of cannabinoids and temozolomide against glioma

Sofía Torres1, Mar Lorente, Fátima Rodríguez-Fornés

  • 1Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, C/José Antonio Novais s/n, 28040 Madrid, Spain.

Molecular Cancer Therapeutics
|January 12, 2011
PubMed

Insights

This study shows that combining Δ(9)-Tetrahydrocannabinol (THC) with temozolomide (TMZ) effectively treats glioblastoma. This drug combination enhances autophagy, a process crucial for killing cancer cells, even in treatment-resistant tumors.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Biology

Background:

  • Glioblastoma multiforme (GBM) is a highly treatment-resistant brain cancer with a poor patient prognosis.
  • Current therapies for GBM have limited efficacy, necessitating novel therapeutic strategies.
  • Cannabinoids, like Δ(9)-Tetrahydrocannabinol (THC), show potential in inhibiting cancer growth by inducing autophagy-mediated apoptosis.

Purpose of the Study:

  • To investigate the combined therapeutic effect of THC and temozolomide (TMZ) on glioblastoma growth.
  • To explore the role of autophagy in the anti-glioma mechanism of the THC and TMZ combination.
  • To evaluate the efficacy of cannabinoids (THC and cannabidiol, CBD) in combination with TMZ against both TMZ-sensitive and TMZ-resistant glioblastoma models.

Main Methods:

  • In vivo studies using glioma xenografts in animal models.
  • Administration of THC, TMZ, and their combination.
  • Assessment of tumor growth inhibition and autophagy markers.
  • Pharmacological and genetic inhibition of autophagy to elucidate its role.
  • Evaluation of combination therapy with submaximal doses of THC and CBD alongside TMZ.

Main Results:

  • Combined THC and TMZ administration demonstrated significant anti-tumoral activity in glioma xenografts.
  • This combination therapy was effective even in tumors resistant to TMZ treatment.
  • THC and TMZ combination enhanced autophagy, and inhibiting autophagy blocked the drug-induced cancer cell death.
  • Submaximal doses of THC and CBD combined with TMZ showed potent anti-glioma effects in both sensitive and resistant tumors.

Conclusions:

  • The combination of TMZ and cannabinoids (THC and CBD) exhibits strong anti-glioblastoma activity.
  • Autophagy activation is a critical mechanism underlying the efficacy of the TMZ and cannabinoid combination.
  • This combination therapy holds therapeutic potential for managing glioblastoma, including treatment-resistant cases.

More Related Videos

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Evaluating In Vitro DNA Damage Using Comet Assay10:43

Evaluating In Vitro DNA Damage Using Comet Assay

Published on: October 11, 2017

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...